2023
28 August, 2023
FluoGuide A/S issues warrants to the investors participating in the directed share issue
Copenhagen, Denmark, 28 August 2023 – FluoGuide A/S (“FluoGuide” or the “Company”) is pleased to announce...
Copenhagen, Denmark, 31 July 2023 – FluoGuide A/S (“FluoGuide” or the “Company”) is pleased to announce...
Copenhagen, Denmark, 25 July 2023 – FluoGuide A/S (“FluoGuide” or the “Company”) held an extraordinary...
7 July, 2023
FluoGuide convenes an extraordinary general meeting
Copenhagen, Denmark, 7 July 2023 – FluoGuide A/S (“FluoGuide” or the “Company”) hereby invites shareholders...
FluoGuide A/S (“FluoGuide” or the “Company”), a Danish biotech company that pioneers precision cancer surgery...
20 June, 2023
FluoGuide announces positive interim results from phase IIa trial of FG001 in head & neck cancer
FluoGuide A/S (“FluoGuide” or the “Company”), a Danish biotech company that pioneers precision cancer surgery...
7 June, 2023
FluoGuide announces positive topline results from phase IIa trial of FG001 in lung cancer
FluoGuide A/S (“FluoGuide” or the “Company”), a Danish biotech company that pioneers precision cancer surgery...
Copenhagen, Denmark, 31 May 2023 – FluoGuide A/S (“FluoGuide” or the “Company”) today releases its results...
FluoGuide A/S (“FluoGuide” or the “Company”), a Danish biotech company that pioneers precision cancer surgery...
Calendar &
upcoming reports
29 November 2023
8-10 January 2024
31 January 2024
Økonomisk Ugebrev Life Science Investor Conference
28 February 2024